Augusta University
Also known as: Abdullah Kutlar | Anand Jillella | Augusta University | Augusta University Georgia Cancer Center | Augusta University Medical Center | Brian Miller | Charbonnier Professor Emeritus of Neurology | David Hess, MD | Dental College of Georgia- Augusta University | Dental College of Georgia-Augusta University | Department of Pediatrics, Medical College of Georgia, Augusta University | Geogia Health Sciences University | Georgia Cancer Center | Georgia Cancer Center at Augusta University | Georgia Health Sciences University | Georgia Health Sciences University, Augusta, Georgia | Georgia Health Sciences University Department of Psychiatry and Health Behavior | Georgia Regents University | GHSU-College of Dental Medicine | James Gossage | Medical College of Georgia at Augusta University, Department of Psychiatry and Health Behavior, Augusta, GA | Nagla Karim | Samir N. Khleif | Southeastern Clinical Research Institute, LLC 1521, Anthony Road Augusta, GA 30904 | Theodore S. Johnson
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2001Last known activity
Oct 31, 2024
Timeline
1820s
- Jan 1, 1828
Augusta University— Founded
Drugs by trial phase (127 distinct, 104 trials)
Phase 4 (24 own, 0 via acquisition)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (39 own, 0 via acquisition)
Phase 1 (23 own, 0 via acquisition)
Other trials (30 own, 0 via acquisition)
Indications
Studied for
- Alcoholism
- Anemia
- Anemia, Sickle Cell
- Arteriovenous Malformations
- Asperger Syndrome
- Asthma
- Body Weight
- Body Weight Changes
- Bradycardia
- Brain Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Transitional Cell
- Cardiac Complexes, Premature
- Cardiovascular Abnormalities
- Cardiovascular Diseases
- Cerebral Hemorrhage
- Cervical Intraepithelial Neoplasia
- Colonic Neoplasms
- Congenital Abnormalities
- Constipation
- Cystic Fibrosis
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Disease
- Drug-Related Side Effects and Adverse Reactions
- Dyslipidemias
- Ependymoma
- Epistaxis
- Esophageal Motility Disorders
- Esophageal Spasm, Diffuse
- Fibrosis
- Gastrointestinal Hemorrhage
- Glioblastoma
- Glucose Intolerance
- Head and Neck Neoplasms
- Hemangioma
- Hematologic Neoplasms
- Hemorrhage
- HIV-Associated Lipodystrophy Syndrome
- Hyperglycemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypersensitivity
- Hypertension
- Hypertension, Renal
- Hypoxia
- Infertility
- Infertility, Female
- Infertility, Male
- Insulin Resistance
- Irritable Bowel Syndrome
- Kidney Diseases
- Labor Pain
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lipodystrophy
- Liver Diseases
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Lymphoma, Mantle-Cell
- Major Depressive Disorder
- Medulloblastoma
- Mental Disorders
- Mesothelioma
- Metabolic Diseases
- Neoplasm Metastasis
- Neoplasms
- Obesity
- Pancreatic Neoplasms
- Papilloma
- Periodontal Diseases
- Postoperative Pain
- Prediabetic State
- Pregnancy, Ectopic
- Prehypertension
- Prostatic Neoplasms
- Psychomotor Agitation
- Psychotic Disorders
- Pulmonary Disease, Chronic Obstructive
- Recurrence
- Renal Insufficiency, Chronic
- Restless Legs Syndrome
- Schizophrenia
- Sleep Initiation and Maintenance Disorders
- Small Cell Lung Carcinoma
- Squamous Intraepithelial Lesions of the Cervix
- Status Asthmaticus
- Stress Disorders, Post-Traumatic
- Stress Disorders, Traumatic
- Stress, Psychological
- Stroke
- Substance-Related Disorders
- Suicidal Ideation
- Telangiectasia, Hereditary Hemorrhagic
- Telangiectasis
Recent trials (50)
- NCT06588413Sponsor investigatorPhase 3Oct 31, 2024
- NCT06588413Lead sponsorPhase 3Oct 31, 2024
- NCT06142396Overall official - principal investigatorEarly Phase 1Jan 1, 2024
- NCT06142396Lead sponsorEarly Phase 1Jan 1, 2024
- NCT05846880Overall official - principal investigatorEarly Phase 1Dec 31, 2023
- NCT05846880Lead sponsorEarly Phase 1Dec 31, 2023
- NCT05846880Sponsor investigatorEarly Phase 1Dec 31, 2023
- NCT05228535Lead sponsorN/AApr 11, 2022
- NCT05106296Sponsor investigatorPhase 1Feb 28, 2022
- NCT05106296Lead sponsorPhase 1Feb 28, 2022
- NCT05106296CollaboratorPhase 1Feb 28, 2022
- NCT05143840Lead sponsorPhase 2Feb 28, 2022
- NCT05106296Overall official - principal investigatorPhase 1Feb 28, 2022
- NCT05157295Study directorPhase 4Jan 1, 2022
- NCT05157295Overall official - principal investigatorPhase 4Jan 1, 2022
Details
- Founded
- Augusta, GA, US Jan 1, 1828
- Last known activity
- Oct 31, 2024